TY - JOUR
T1 - Patient and physician shared decision-making behaviors in oncology
T2 - Evidence on adequate measurement properties of the iSHARE questionnaires
AU - Bomhof-Roordink, Hanna
AU - Stiggelbout, Anne M
AU - Gärtner, Fania R
AU - Portielje, Johanneke E A
AU - de Kroon, Cor D
AU - Peeters, Koen C M J
AU - Neelis, Karen J
AU - Dekker, Jan Willem T
AU - van der Weijden, Trudy
AU - Pieterse, Arwen H
AU - iSHARE Study group
AU - Boersma, Liesbeth
AU - Buijsen, Johannes
N1 - Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
PY - 2022/5
Y1 - 2022/5
N2 - OBJECTIVES: We have developed two Dutch questionnaires to assess the shared decision-making (SDM) process in oncology; the iSHAREpatient and iSHAREphysician. In this study, we aimed to determine: scores, construct validity, test-retest agreement (iSHAREpatient), and inter-rater (iSHAREpatient-iSHAREphysician) agreement.METHODS: Physicians from seven Dutch hospitals recruited cancer patients, and completed the iSHAREphysician and SDM-Questionnaire-physician version. Their patients completed the: iSHAREpatient, nine-item SDM-Questionnaire, Decisional Conflict Scale, Combined Outcome Measure for Risk communication And treatment Decision-making Effectiveness, and five-item Perceived Efficacy in Patient-Physician Interactions. We formulated, respectively, one (iSHAREphysician) and 10 (iSHAREpatient) a priori hypotheses regarding correlations between the iSHARE questionnaires and questionnaires assessing related constructs. To assess test-retest agreement patients completed the iSHAREpatient again 1-2 weeks later.RESULTS: In total, 151 treatment decision-making processes with unique patients were rated. Dimension and total iSHARE scores were high both in patients and physicians. The hypothesis on the iSHAREphysician and 9/10 hypotheses on the iSHAREpatient were confirmed. Test-retest and inter-rater agreement were>.60 for most items.CONCLUSIONS: The iSHARE questionnaires show high scores, have good construct validity, substantial test-retest agreement, and moderate inter-rater agreement.PRACTICE IMPLICATIONS: Results from the iSHARE questionnaires can inform both physician- and patient-directed efforts to improve SDM in clinical practice.
AB - OBJECTIVES: We have developed two Dutch questionnaires to assess the shared decision-making (SDM) process in oncology; the iSHAREpatient and iSHAREphysician. In this study, we aimed to determine: scores, construct validity, test-retest agreement (iSHAREpatient), and inter-rater (iSHAREpatient-iSHAREphysician) agreement.METHODS: Physicians from seven Dutch hospitals recruited cancer patients, and completed the iSHAREphysician and SDM-Questionnaire-physician version. Their patients completed the: iSHAREpatient, nine-item SDM-Questionnaire, Decisional Conflict Scale, Combined Outcome Measure for Risk communication And treatment Decision-making Effectiveness, and five-item Perceived Efficacy in Patient-Physician Interactions. We formulated, respectively, one (iSHAREphysician) and 10 (iSHAREpatient) a priori hypotheses regarding correlations between the iSHARE questionnaires and questionnaires assessing related constructs. To assess test-retest agreement patients completed the iSHAREpatient again 1-2 weeks later.RESULTS: In total, 151 treatment decision-making processes with unique patients were rated. Dimension and total iSHARE scores were high both in patients and physicians. The hypothesis on the iSHAREphysician and 9/10 hypotheses on the iSHAREpatient were confirmed. Test-retest and inter-rater agreement were>.60 for most items.CONCLUSIONS: The iSHARE questionnaires show high scores, have good construct validity, substantial test-retest agreement, and moderate inter-rater agreement.PRACTICE IMPLICATIONS: Results from the iSHARE questionnaires can inform both physician- and patient-directed efforts to improve SDM in clinical practice.
KW - AGREEMENT
KW - COMMUNICATION
KW - CONFLICT SCALE
KW - COSMIN
KW - Construct validity
KW - Formative
KW - Hypotheses testing
KW - Inter-rater agreement
KW - MEASUREMENT INSTRUMENTS
KW - METHODOLOGICAL QUALITY
KW - Oncology
KW - PERCEIVED EFFICACY
KW - PSYCHOMETRIC PROPERTIES
KW - Questionnaire
KW - SYSTEMATIC REVIEWS
KW - Shared decision-making
KW - Test-retest agreement
KW - VALIDATION
U2 - 10.1016/j.pec.2021.08.034
DO - 10.1016/j.pec.2021.08.034
M3 - Article
C2 - 34556384
SN - 0738-3991
VL - 105
SP - 1089
EP - 1100
JO - Patient Education and Counseling
JF - Patient Education and Counseling
IS - 5
ER -